Showing results (451-460 of 477) with videos related to
Sort By:
Pageof 48
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2022
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trialMichael Behnes, Shqipdona Lahu, Gjin Ndrepepa, et al.European Heart Journal Open|January 19, 2023
Predictive value of late gadolinium enhancement cardiovascular magnetic resonance in patients with persistent atrial fibrillation: dual-centre validation of a standardized methodTill F Althoff, Martin Eichenlaub, David Padilla-Cueto, et al.Thrombosis and Haemostasis|August 8, 2017
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stentsYukinori Harada, Jonathan Michel, Raphaela Lohaus, et al.American Heart Journal|June 20, 2012
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trialHolger Thiele, Gerhard Schuler, Franz-Josef Neumann, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 13, 2024
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrelAlp Aytekin, Maria Scalamogna, J J Coughlan, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 5, 2017
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysisStuart J Head, Bruno R da Costa, Berend Beumer, et al.JAMA Cardiology|June 30, 2021
Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical TrialJ J Coughlan, Alp Aytekin, Shqipdona Lahu, et al.Journal of the American College of Cardiology|November 19, 2021
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCIMarco Valgimigli, Davide Cao, Dominick J Angiolillo, et al.Thrombosis and Haemostasis|September 23, 2016
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) TrialDirk Sibbing, Dániel Aradi, Claudius Jacobshagen, et al.JACC. Cardiovascular Interventions|November 6, 2020
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed TomographyOle De Backer, Uri Landes, Andreas Fuchs, et al.Pageof 48